Variant report
Variant | esv3434870 |
---|---|
Chromosome Location | chr1:165497978-165500276 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAFK | chr1:165500263-165500465 | HepG2 | liver: | n/a | chr1:165500355-165500366 chr1:165500355-165500366 chr1:165500350-165500365 |
2 | POLR2A | chr1:165498868-165498873 | K562 | blood: | n/a | n/a |
3 | POLR2A | chr1:165499611-165499768 | K562 | blood: | n/a | n/a |
4 | STAT3 | chr1:165500234-165500402 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | ZNF274 | chr1:165498846-165499245 | K562 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:165480828..165483670-chr1:165500006..165502209,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RXRG-1 | chr1:165498020-165498119 | NONHSAT007314 |
2 | lnc-RXRG-1 | chr1:165498020-165498121 | ENSG00000237463.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000237463 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543801154 | chr1:165498056-165498057 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs557397641 | chr1:165498070-165498071 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs574156380 | chr1:165498071-165498072 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs537511346 | chr1:165498152-165498153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375138952 | chr1:165498169-165498170 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543124620 | chr1:165498202-165498203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2114047 | chr1:165498211-165498212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559258952 | chr1:165498254-165498255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs16846410 | chr1:165498289-165498290 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs187798672 | chr1:165498303-165498304 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs176230 | chr1:165498335-165498336 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs398297 | chr1:165498357-165498358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192760979 | chr1:165498390-165498391 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554434074 | chr1:165498458-165498459 | Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1913840 | chr1:165498472-165498473 | Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs34505661 | chr1:165498526-165498527 | Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs57131010 | chr1:165498596-165498597 | Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs12060030 | chr1:165498640-165498641 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs58628453 | chr1:165498651-165498652 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs375130269 | chr1:165498781-165498782 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34548882 | chr1:165498798-165498799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs71732157 | chr1:165498799-165498800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs28396786 | chr1:165498804-165498805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3074728 | chr1:165498806-165498807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs61511522 | chr1:165498807-165498808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113949707 | chr1:165498825-165498826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149185014 | chr1:165498853-165498854 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs184171302 | chr1:165498859-165498860 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs7550844 | chr1:165498860-165498861 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs571924659 | chr1:165498864-165498865 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs2162143 | chr1:165498918-165498919 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs12058992 | chr1:165498921-165498922 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs546620144 | chr1:165498941-165498942 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs376754279 | chr1:165498942-165498943 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs386368574 | chr1:165498943-165498944 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs59443114 | chr1:165498944-165498945 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs552599738 | chr1:165498954-165498955 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs62648294 | chr1:165499020-165499021 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs143326316 | chr1:165499053-165499054 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs62641621 | chr1:165499063-165499064 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs61800607 | chr1:165499088-165499089 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs200392780 | chr1:165499093-165499094 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs67030470 | chr1:165499096-165499097 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs201592399 | chr1:165499097-165499098 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs60679525 | chr1:165499098-165499099 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs398103322 | chr1:165499101-165499102 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs61800608 | chr1:165499102-165499103 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs542749092 | chr1:165499105-165499106 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs149126149 | chr1:165499145-165499146 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs138190491 | chr1:165499154-165499155 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Glomerulonephritis | 19341492 | CNVD |
Systemic lupus erythematosus | 18559452 | CNVD |
Systemic autoimmune disease | 17597778 | CNVD |
Glomerulonephritis | 17008540 | CNVD |
Glomerulonephritis | 16482158 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20409316 | CNVD |
Mental retardation | 17847001 | CNVD |
Idiopathic thrombocytopenic purpura | 17827395 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 22522925 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:165497000-165501400 | Weak transcription | Left Ventricle | heart |
2 | chr1:165497200-165499400 | Weak transcription | Fetal Muscle Leg | muscle |
3 | chr1:165497200-165499400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
4 | chr1:165497200-165501400 | Weak transcription | Right Ventricle | heart |
5 | chr1:165497400-165498400 | Enhancers | Fetal Heart | heart |
6 | chr1:165498400-165498600 | Flanking Active TSS | Fetal Heart | heart |
7 | chr1:165498600-165498800 | Enhancers | Fetal Heart | heart |
8 | chr1:165498800-165499200 | Weak transcription | Fetal Heart | heart |
9 | chr1:165499200-165501800 | Enhancers | Fetal Heart | heart |
10 | chr1:165499400-165499600 | Enhancers | Fetal Muscle Leg | muscle |
11 | chr1:165499400-165499600 | Enhancers | Right Atrium | heart |
12 | chr1:165499400-165499800 | Enhancers | Psoas Muscle | Psoas |
13 | chr1:165499400-165502800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
14 | chr1:165499400-165504200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
15 | chr1:165499600-165500000 | Weak transcription | Fetal Muscle Leg | muscle |
16 | chr1:165499600-165500400 | Weak transcription | Right Atrium | heart |
17 | chr1:165499800-165500800 | Weak transcription | Psoas Muscle | Psoas |
18 | chr1:165500000-165500400 | Enhancers | Fetal Lung | lung |
19 | chr1:165500000-165501000 | Enhancers | Liver | Liver |
20 | chr1:165500000-165503000 | Enhancers | Fetal Muscle Leg | muscle |
21 | chr1:165500200-165500800 | Enhancers | Adipose Nuclei | Adipose |